| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794176 | Ophthalmology | 2018 | 10 Pages |
Abstract
Participants with AMD have altered plasma metabolomic profiles compared with controls. Our data suggest that the most significant metabolites map to the glycerophospholipid pathway. These findings have the potential to improve our understanding of AMD pathogenesis, to support the development of plasma-based metabolomics biomarkers of AMD, and to identify novel targets for treatment of this blinding disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Inês MD, MSc, Rachel S. PhD, John B. MD, Rufino MD, PhD, Demetrios G. MD, PhD, Ivana K. MD, Joaquim N. MD, PhD, Jessica PhD, Joan W. MD, Deeba MD,